United States· US:70709-062_eb717a3b-e703-4637-83c7-fccdecbac199
TASCENSO ODT
A medicinal product containing fingolimod lauryl sulfate, registered in United States by Cycle Pharmaceuticals Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FINGOLIMOD LAURYL SULFATE
- Manufacturer
- Cycle Pharmaceuticals Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- August 23, 2026
Packs & prices · 2
- ndc1170709062303 BLISTER PACK in 1 CARTON (70709-062-30) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
- ndc1170709-062-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac1fc241-1dd7-46dc-872d-08a6202db81b GET /v1/drugs/ac1fc241-1dd7-46dc-872d-08a6202db81b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".25",
"substance": "FINGOLIMOD LAURYL SULFATE",
"productndc": "70709-062",
"dosage_form": "TABLET, ORALLY DISINTEGRATING",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA214962",
"marketing_category": "NDA"
}See everything about fingolimod lauryl sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.